New Jersey Clinical Trials
Browse actively recruiting clinical trials with research sites in New Jersey. Corterve gathers current studies from the public ClinicalTrials.gov registry so you can explore them by city and condition. Participation is voluntary; this page is general information and not medical advice.
Recruiting studies in New Jersey
- Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)NCT06095583Limited-stage Small Cell Lung Cancer (LS-SCLC)New Brunswick, NJ
- Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder CancerNCT06995677Low-grade NMIBCMorristown, NJ
- A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)NCT05519085Relapsed or Refractory Multiple MyelomaEast Brunswick, NJ
- A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)NCT06667076Carcinoma, Non-Small-Cell LungFlemington, NJ
- A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.NCT05355701MelanomaMiddletown, NJ
- Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk NeuroblastomaNCT06172296Ganglioneuroblastoma, NodularHackensack, NJ
- GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyNCT03821129StrokeFreehold, NJ
- Gene Therapy for HER-Positive Cancer (SENTRY-HER2)NCT07192432HER2 Expressing Solid TumorsHackensack, NJ
- Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung CancerNCT06287775Extensive Stage Lung Small Cell CarcinomaBasking Ridge, NJ
- Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1NCT07563881Focal SeizureHackensack, NJ
- A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood PressureNCT06742723Chronic Kidney Disease and HypertensionEatontown, NJ
- A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade GliomaNCT04166409Low Grade AstrocytomaMorristown, NJ
Popular conditions in New Jersey
Frequently asked questions
- How do I find clinical trials in New Jersey?
- Corterve aggregates actively recruiting clinical trials with sites in New Jersey from the public ClinicalTrials.gov registry. Browse the studies on this page or take a free health assessment to find trials you may qualify for.
- Are clinical trials in New Jersey free to join?
- Study participation is typically free — sponsors cover the investigational treatment and study-related visits, and many studies compensate participants for time and travel. Details vary by study.
- What kinds of clinical trials are available in New Jersey?
- New Jersey research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.